LNSR · TickerCove

LNSRLENSAR IncHealthcare · Medical - Equipment & Servicesas of 2026-09-16

Horizon

Issued 2026-09-16 at $7.08 · now $7.08 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, LNSR has typically landed between $5.43 and $9.61 — a range of −23.3% to +35.7% from the issuance price $7.08.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

1,474 overlapping 1 month windows · 2020-10-02 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($7.08) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$7.08 · 27% of range

$5.01 low$12.73 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

−1.1%

typical move · IQR 19.5%

−23.3%worst (p90)+35.7%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where LNSR has typically landed a month from the 2026-09-16 close of $7.08 — the range is history, not a prediction.

now $7.08 (+0.0%)
typical $7 (-1.1%)
middle 50% $6.31–$7.69
90% range $5.43–$9.61

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 1,474 windows spanning 2020-10-02 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2026-02-25	−54.5%	−54.5%	+0.6%
2026-03-09	−53.5%	−53.6%	+0.0%
2026-02-24	−53.3%	−53.5%	+2.2%
3 best
2023-12-12	+102.3%	−1.4%	+102.3%
2023-12-11	+96.0%	−4.0%	+96.0%
2023-12-13	+82.5%	+0.0%	+105.1%

1,474 overlapping windows · 2020-10-02 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~6 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

67%

+5.4%

n=6

Feb

67%

+13.1%

n=6

Mar

33%

−14.1%

n=6

Apr

17%

−2.1%

n=6

May

67%

+12.2%

n=6

Jun

33%

+6.2%

n=6

Jul

17%

−6.0%

n=6

Aug

50%

+9.1%

n=6

Sep

33%

−6.2%

n=6

Oct

20%

−5.5%

n=5

Nov

33%

−2.7%

n=6

Dec

50%

+6.0%

n=6

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

34 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-06-03	CURTIS NICHOLAS T	director	Award / grant	130,662	1,122,758	Form 4
2026-06-03	Connaughton Alan B.	officer	Award / grant	34,843	389,173	Form 4
2026-06-03	ELLIS THOMAS B	director	Award / grant	17,421	56,083	Form 4
2026-06-03	HAMMER TODD B	director	Award / grant	17,421	56,083	Form 4
2026-06-03	LINK WILLIAM J PHD	director	Award / grant	17,421	568,062	Form 4
2026-06-03	LINDSTROM RICHARD L MD	director	Award / grant	17,421	263,831	Form 4
2026-06-03	Winer Gary M	director	Award / grant	17,421	105,635	Form 4
2026-06-03	O'Farrell Elizabeth G.	director	Award / grant	17,421	67,368	Form 4
2026-06-03	WEISNER AIMEE S	director	Award / grant	17,421	110,368	Form 4
2026-06-03	Wong Kendra	officer	Award / grant	13,066	56,481	Form 4
2026-05-06	STAAB THOMAS R II	officer	Withheld for tax	1,350	174,609	Form 4
2026-05-06	Wong Kendra	officer	Withheld for tax	864	43,415	Form 4
2026-05-06	CURTIS NICHOLAS T	director	Other acquisition	0	992,096	Form 4
2026-03-19	STAAB THOMAS R II	officer	Option exercise	5,500	175,959	Form 4
2026-03-19	STAAB THOMAS R II	officer	Option exercise	5,500	14,295	Form 4
2026-02-18	Connaughton Alan B.	officer	Withheld for tax	2,392	357,069	Form 4
2026-02-18	STAAB THOMAS R II	officer	Withheld for tax	1,076	170,459	Form 4
2026-02-18	CURTIS NICHOLAS T	director	Other acquisition	0	992,096	Form 4
2026-01-11	Connaughton Alan B.	officer	Withheld for tax	2,262	359,461	Form 4
2026-01-11	STAAB THOMAS R II	officer	Withheld for tax	1,826	171,535	Form 4
2026-01-11	CURTIS NICHOLAS T	director	Other acquisition	0	992,096	Form 4
2025-05-23	LINK WILLIAM J PHD	director	Award / grant	7,374	550,641	Form 4
2025-05-23	WEISNER AIMEE S	director	Award / grant	7,374	92,947	Form 4
2025-05-23	Winer Gary M	director	Award / grant	7,374	88,214	Form 4
2025-05-23	O'Farrell Elizabeth G.	director	Award / grant	7,374	49,947	Form 4
2025-05-23	ELLIS THOMAS B	director	Award / grant	7,374	38,662	Form 4
2025-05-23	HAMMER TODD B	director	Award / grant	7,374	38,662	Form 4
2025-05-23	LINDSTROM RICHARD L MD	director	Award / grant	7,374	246,410	Form 4
2025-02-18	STAAB THOMAS R II	officer	Award / grant	12,766	173,361	Form 4
2025-02-18	CURTIS NICHOLAS T	director	Award / grant	127,660	992,096	Form 4
2025-02-18	Connaughton Alan B.	officer	Award / grant	37,234	361,723	Form 4
2025-02-18	Wong Kendra	officer	Award / grant	6,383	42,236	Form 4
2025-01-11	STAAB THOMAS R II	officer	Withheld for tax	1,839	160,595	Form 4
2025-01-11	Wong Kendra	officer	Withheld for tax	1,132	35,853	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i